CYTOKINETICS, INCORPORATED Long-Term Debt
CYTOKINETICS, INCORPORATED (CYTK) had Long-Term Debt of $248.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2026-08-06
- 2026-06-30: Long-term Debt, Excluding Current Maturities $248.20M.
- 2026-03-31: Long-term Debt, Excluding Current Maturities $247.21M.
- 2025-12-31: Long-term Debt, Excluding Current Maturities $246.38M.
- 2025-09-30: Long-term Debt, Excluding Current Maturities $158.75M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2026-06-30 | $248.20M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $247.21M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $246.38M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $158.75M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $159.06M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $92.03M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $93.23M 10-K · filed 2026-02-26 |
| 2024-09-30 | $93.02M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $92.83M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $56.82M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $58.38M 10-K · filed 2025-02-27 |
| 2023-09-30 | $60.88M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $62.49M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $64.11M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $63.81M 10-K · filed 2024-02-28 |
| 2022-09-30 | $63.54M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $62.34M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $61.16M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $47.37M 10-K · filed 2023-03-01 |
| 2021-09-30 | $30.20M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $35.54M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $40.87M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $46.21M 10-K · filed 2022-02-25 |
| 2020-09-30 | $45.92M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $45.63M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $45.34M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $45.05M 10-K · filed 2021-02-26 |
| 2019-09-30 | $44.76M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $44.47M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $36.38M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $39.81M 10-K · filed 2020-03-04 |
| 2018-09-30 | $38.13M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $30.66M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $31.95M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $31.78M 10-K · filed 2019-03-07 |
| 2017-09-30 | $20.47M 10-Q · filed 2017-11-03 |
| 2017-06-30 | $22.84M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $25.20M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $27.38M 10-K · filed 2018-03-05 |
| 2016-09-30 | $29.74M 10-Q/A · filed 2016-12-15 |
| 2016-06-30 | $29.60M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $29.47M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $14.64M 10-K · filed 2017-03-06 |
| 2014-12-31 | $0.00 10-K · filed 2016-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |